A Year with COVID-19: Scientific Engagements Pulse Check
This paper describes survey results from Amgen JAPAC Medical Affairs examining the current state in early 2021 of medical engagement amongst healthcare professionals.
This paper describes survey results from Amgen JAPAC Medical Affairs examining the current state in early 2021 of medical engagement amongst healthcare professionals.
Here we explore how some of the top Medical Affairs leaders from Johnson & Johnson think about career leadership development opportunities and challenges.
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
“If you ask patient communities their major concerns, it’s affordable access,” says Alissa Heizler-Mendoza speaking about patient advocacy in Medical Affairs.
MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.
J&J leaders detail how to think about managing the challenge of broadening the focus of a Medical Affairs career to encompass new and multiple therapeutic areas.
This MAPS podcast identifies potential areas for compliant collaboration by medical science liaisons with key internal Medical Affairs partners
This report shares the key insights from a MAPS special session on Field Medical engagement and provides further context from Medical Affairs colleagues who have first-hand knowledge of the ever-changing Field Medical role.
The objective of this podcast is to discuss how the 21st Century Cures Act has led to new initiatives at FDA involving Real World Evidence.
This 8th episode in our Field Medical podcast series explores the evolving roles of MSLs in the context of clinical trials.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.